Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera - PubMed (original) (raw)
. 1995 May 12;270(19):11502-13.
doi: 10.1074/jbc.270.19.11502.
Affiliations
- PMID: 7744790
- DOI: 10.1074/jbc.270.19.11502
Free article
Analysis of the hormone-dependent regulation of a JunD-estrogen receptor chimera
M K Francis et al. J Biol Chem. 1995.
Free article
Abstract
The modular ligand-binding domains of steroid receptors have been widely used to generate protein chimeras that are ligand dependent for activity. In a similar manner, we generated a series of conditionally active JunD and c-Fos proteins by fusing their carboxyl (COOH)-terminal ends with a COOH-terminal fragment of the human estrogen receptor (ER) that contains the ligand-binding domain. JunD-ER (DER) and Fos-ER (FER) chimeras with an intact leucine zipper and basic region exhibit hormone-dependent activation of activator protein-1-directed transcription in transient expression assays. One of these fusions, DER, has been examined in detail to determine its mechanism of action. Results from immunoprecipitation experiments with extracts from DER and Fos transfected cells demonstrate that Fos and DER readily form heterodimer complexes. Surprisingly, the formation of Fos:DER heterodimers, and possibly DER homodimers, is estrogen-independent. However, gel shift assays clearly demonstrate that DNA binding to AP1 sites by Fos:DER heterodimers or DER homodimers is estrogen-dependent. Moreover, in the absence of estrogen, the DER protein is an effective inhibitor of Fos-mediated transactivation, and this effect is reversed by the presence of estrogen. Our results indicate that the DER protein is a direct, hormone-reversible inhibitor of Fos and that estrogen controls the conditional positive or dominant negative activities of DER at the level of DNA binding to AP1 sites. Accordingly, clonally derived fibroblast cell lines that stably express the DER protein exhibit reduced entry into the S phase of the cell cycle when quiescent cells are serum stimulated in the absence of estrogen. This is in contrast to the estrogen-treated controls. These results support the hypothesis that AP1 is important for cell cycle progression and provide a unique approach for examining the role of AP1 in this process.
Similar articles
- Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.
Teyssier C, Belguise K, Galtier F, Chalbos D. Teyssier C, et al. J Biol Chem. 2001 Sep 28;276(39):36361-9. doi: 10.1074/jbc.M101806200. Epub 2001 Jul 26. J Biol Chem. 2001. PMID: 11477071 - Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site.
Petz LN, Ziegler YS, Schultz JR, Nardulli AM. Petz LN, et al. Mol Endocrinol. 2004 Mar;18(3):521-32. doi: 10.1210/me.2003-0105. Epub 2003 Dec 18. Mol Endocrinol. 2004. PMID: 14684847 - Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
Strahl BD, Huang HJ, Pedersen NR, Wu JC, Ghosh BR, Miller WL. Strahl BD, et al. Endocrinology. 1997 Jun;138(6):2621-31. doi: 10.1210/endo.138.6.5205. Endocrinology. 1997. PMID: 9165057 - Reactive oxygen intermediates (ROIs) are involved in the intracellular transduction of angiotensin II signal in C2C12 cells.
Puri PL, Avantaggiati ML, Burgio VL, Chirillo P, Collepardo D, Natoli G, Balsano C, Levrero M. Puri PL, et al. Ann N Y Acad Sci. 1995 Mar 27;752:394-405. doi: 10.1111/j.1749-6632.1995.tb17447.x. Ann N Y Acad Sci. 1995. PMID: 7755283 Review.
Cited by
- Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms.
Burns KA, Li Y, Arao Y, Petrovich RM, Korach KS. Burns KA, et al. J Biol Chem. 2011 Apr 8;286(14):12640-9. doi: 10.1074/jbc.M110.187773. Epub 2011 Feb 1. J Biol Chem. 2011. PMID: 21285458 Free PMC article. - Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene.
Venugopal R, Jaiswal AK. Venugopal R, et al. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14960-5. doi: 10.1073/pnas.93.25.14960. Proc Natl Acad Sci U S A. 1996. PMID: 8962164 Free PMC article. - Research resource: comparison of gene profiles from wild-type ERα and ERα hinge region mutants.
Burns KA, Li Y, Liu L, Korach KS. Burns KA, et al. Mol Endocrinol. 2014 Aug;28(8):1352-61. doi: 10.1210/me.2014-1122. Epub 2014 Jun 20. Mol Endocrinol. 2014. PMID: 24947674 Free PMC article. - Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB, Milne T, García-Cuéllar MP, Schreiner S, Martin ME, Fuchs U, Borkhardt A, Chanda SK, Walker J, Soden R, Hess JL, Slany RK. Zeisig BB, et al. Mol Cell Biol. 2004 Jan;24(2):617-28. doi: 10.1128/MCB.24.2.617-628.2004. Mol Cell Biol. 2004. PMID: 14701735 Free PMC article. - Hormone-regulatable neoplastic transformation induced by a Jun-estrogen receptor chimera.
Kruse U, Iacovoni JS, Goller ME, Vogt PK. Kruse U, et al. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12396-400. doi: 10.1073/pnas.94.23.12396. Proc Natl Acad Sci U S A. 1997. PMID: 9356460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials